Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Yuki Kodono
Japan Regional Product Lifecycle Management
Takeda Pharmaceutical Company Limited, Japan
Poster(s):
(W1130-02-13) Multi-Compartment In Vitro Dissolution Testing to Study the Potential Impact of API Changes on Drug-in-Capsule Absorption for Mobocertinib, a Weak Base with Complex pH-Dependent Solubility
Wednesday, November 12, 2025
11:30 AM - 12:30 PM
CT
(M1230-05-31) Physiologically Based Biopharmaceutics Modeling of Formulation Bioequivalence for Mobocertinib, a Weak Base, Using pH-Dependent Dissolution Data
Monday, November 10, 2025
12:30 PM - 1:30 PM
CT
